Boost ROI through automated sample prep, AI analytics, high-throughput testing, portfolio expansion via acquisitions, and regional production to reduce tariff exposure.Dublin, Oct. 14, 2026 (GLOBE ...
CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry ...
Flow cytometry continues to transform biological research by enabling rapid, high-dimensional analysis of millions of individual cells. As researchers seek deeper insights into cellular heterogeneity, ...
Zacks Investment Research on MSN
Here's why you should retain WAT stock in your portfolio for now
Waters WAT is well-poised for growth in the coming quarters, driven by sustained demand for analytical sciences, an extended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results